Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 24;13(11):3092.
doi: 10.3390/jcm13113092.

Impact of a Novel Antiseptic Lavage Solution on Acute Periprosthetic Joint Infection in Hip and Knee Arthroplasty

Affiliations

Impact of a Novel Antiseptic Lavage Solution on Acute Periprosthetic Joint Infection in Hip and Knee Arthroplasty

Luca Andriollo et al. J Clin Med. .

Abstract

Background: Periprosthetic joint infection (PJI) represents a challenge following hip or knee arthroplasty, demanding immediate intervention to prevent implant failure and systemic issues. Bacterial biofilm development on orthopedic devices worsens PJI severity, resulting in recurrent hospitalizations and significant economic burdens. The objective of this retrospective cohort study is to evaluate the efficacy of this novel antiseptic solution, never previously evaluated in vivo, in managing early post-operative or acute hematogenous PJI following primary hip and knee joint replacements. Methods: The inclusion criteria consist of patients with total hip arthroplasty (THA) or knee arthroplasty diagnosed with acute PJI through preoperative and intraoperative investigations, in accordance with the MSIS ICM 2018 criteria. The minimum required follow-up was 12 months from the cessation of antibiotic therapy. This novel antiseptic lavage solution is composed of ethanol, acetic acid, sodium acetate, benzalkonium chloride and water. Data included demographic characteristics, diagnostic criteria, surgical techniques, post-operative treatment and follow-up outcomes. Results: A total of 39 patients treated with Debridement, Antibiotics Pearls and Retention of the Implant (DAPRI) procedures using this solution between May 2021 and April 2023 were analyzed. At a mean follow-up of 24.6 ± 6.4 months, infection recurrence-free survival rates were 87.2%, with no local allergic reactions or relevant systemic adverse effects detected. Persistent PJI necessitated two-stage revision surgery. Conclusions: This novel antiseptic lavage solution shows promise as an adjunctive tool in the treatment of PJI, demonstrating support in infection control while maintaining a favorable safety profile.

Keywords: Bactisure Wound Lavage; DAIR; DAPRI; PJI; acute periprosthetic joint infection; joint replacement.

PubMed Disclaimer

Conflict of interest statement

F.B. and S.M.P.R. declare a teaching contract with the manufacturer (Zimmer Biomet). The other authors declare no conflicts of interest related to the present study.

Figures

Figure 1
Figure 1
Diagnostic and Therapeutic Protocol in the Management of Acute Periprosthetic Joint Infection (PJI) (Erythrocyte Sedimentation Rate, ESR; C-Reactive Protein, CRP; physical examination, PE; Debridement, Antibiotic Pearls and Retention of the Implant, DAPRI).
Figure 2
Figure 2
Bactisure® Wound Lavage (Zimmer Biomet, Warsaw, IN, USA) and Pulsavac® Plus (Zimmer Biomet, Warsaw, IN, USA), a pulsatile lavage system required for its application.

Similar articles

Cited by

References

    1. Zimmerli W., Moser C. Pathogenesis and Treatment Concepts of Orthopaedic Biofilm Infections. FEMS Immunol. Med. Microbiol. 2012;65:158–168. doi: 10.1111/j.1574-695X.2012.00938.x. - DOI - PubMed
    1. Osmon D.R., Berbari E.F., Berendt A.R., Lew D., Zimmerli W., Steckelberg J.M., Rao N., Hanssen A., Wilson W.R., Infectious Diseases Society of America Executive Summary: Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2013;56:1–10. doi: 10.1093/cid/cis966. - DOI - PubMed
    1. Izakovicova P., Borens O., Trampuz A. Periprosthetic Joint Infection: Current Concepts and Outlook. EFORT Open Rev. 2019;4:482–494. doi: 10.1302/2058-5241.4.180092. - DOI - PMC - PubMed
    1. Rajput V., Meek R.M.D., Haddad F.S. Periprosthetic Joint Infection: What Next? Bone Joint J. 2022;104-B:1193–1195. doi: 10.1302/0301-620X.104B11.BJJ-2022-0944. - DOI - PubMed
    1. Brochin R.L., Phan K., Poeran J., Zubizarreta N., Galatz L.M., Moucha C.S. Trends in Periprosthetic Hip Infection and Associated Costs: A Population-Based Study Assessing the Impact of Hospital Factors Using National Data. J. Arthroplast. 2018;33:S233–S238. doi: 10.1016/j.arth.2018.02.062. - DOI - PubMed

LinkOut - more resources